메뉴 건너뛰기
Journal of Clinical Psychopharmacology
Volumn 24, Issue 6, 2004, Pages 682-683
Obsessive-compulsive symptoms precipitated by methadone tapering [8]
Author keywords

[No Author keywords available]
Indexed keywords

METHADONE;
EID: 8744223367     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000145338.07676.cb     Document Type: Letter
Times cited : (7)
References (10)
  • 1
    • 0033957052 scopus 로고    scopus 로고
    • Neurobiology of the obsessive-compulsive spectrum disorders
    • Stein DJ. Neurobiology of the obsessive-compulsive spectrum disorders. Biol Psychiatry. 2000;47:296-304.
    • (2000) Biol Psychiatry , vol.47 , pp. 296-304
    • Stein, D.J.1
  • 2
    • 0031846267 scopus 로고    scopus 로고
    • Pharmacotherapy for obsessive-compulsive disorder
    • Gresit JH, Jefferson JW. Pharmacotherapy for obsessive-compulsive disorder. Br J Psychiatry. 1998;173:64-70.
    • (1998) Br J Psychiatry , vol.173 , pp. 64-70
    • Gresit, J.H.1    Jefferson, J.W.2
  • 3
    • 0020572577 scopus 로고
    • Naloxone administration in obsessive-compulsive disorder: Report of two cases
    • Insel TR, Pickar D. Naloxone administration in obsessive-compulsive disorder: report of two cases. Am J Psychiatry. 1983;140:1219-1220.
    • (1983) Am J Psychiatry , vol.140 , pp. 1219-1220
    • Insel, T.R.1    Pickar, D.2
  • 4
    • 0034006867 scopus 로고    scopus 로고
    • Endogenous opioid activity is associated with obsessive-compulsive symptomology in individuals with a family history of alcoholism
    • Mangold DL, Peyrot M, Giggey P, et al. Endogenous opioid activity is associated with obsessive-compulsive symptomology in individuals with a family history of alcoholism. Neuropsychopharmacology. 2000;22:595-607.
    • (2000) Neuropsychopharmacology , vol.22 , pp. 595-607
    • Mangold, D.L.1    Peyrot, M.2    Giggey, P.3
  • 5
    • 0029977409 scopus 로고    scopus 로고
    • Behavioral effects of naloxone infusion in obsessive-compulsive disorder
    • Keuler DJ, Altemus M, Michelson D, et al. Behavioral effects of naloxone infusion in obsessive-compulsive disorder. Biol Psychiatry. 1996;40:154-156.
    • (1996) Biol Psychiatry , vol.40 , pp. 154-156
    • Keuler, D.J.1    Altemus, M.2    Michelson, D.3
  • 6
    • 0023372605 scopus 로고
    • Naloxone abolishes obsessive-compulsive behavior in Tourette's syndrome
    • Sandyk R. Naloxone abolishes obsessive-compulsive behavior in Tourette's syndrome. Int J Neurosci. 1987;35:93-94.
    • (1987) Int J Neurosci , vol.35 , pp. 93-94
    • Sandyk, R.1
  • 7
    • 0030930590 scopus 로고    scopus 로고
    • A possible new treatment approach to obsessive-compulsive disorder
    • Warneke L. A possible new treatment approach to obsessive-compulsive disorder. Can J Psychiatry. 1997;42:667-668.
    • (1997) Can J Psychiatry , vol.42 , pp. 667-668
    • Warneke, L.1
  • 8
    • 0031448045 scopus 로고    scopus 로고
    • Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder
    • Shapira NA, Keck PE Jr, Goldsmith TD, et al. Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder. Depress Anxiety. 1997;6:170-173.
    • (1997) Depress Anxiety , vol.6 , pp. 170-173
    • Shapira, N.A.1    Keck Jr., P.E.2    Goldsmith, T.D.3
  • 9
    • 0032960426 scopus 로고    scopus 로고
    • Rapid remission of OCD with tramadol hydrochloride
    • Goldsmith TD, Shapira NA, Keck PE. Rapid remission of OCD with tramadol hydrochloride. Am J Psychiatry. 1999;156:660-661.
    • (1999) Am J Psychiatry , vol.156 , pp. 660-661
    • Goldsmith, T.D.1    Shapira, N.A.2    Keck, P.E.3
  • 10
    • 0032961745 scopus 로고    scopus 로고
    • Possible role of neuropeptides in obsessive compulsive disorder
    • McDougle J, Barr C, Goodman K, et al. Possible role of neuropeptides in obsessive compulsive disorder. Psychoneuroendocrinology. 1999;24:1-24.
    • (1999) Psychoneuroendocrinology , vol.24 , pp. 1-24
    • McDougle, J.1    Barr, C.2    Goodman, K.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.